GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Veracyte Inc (FRA:12V) » Definitions » Other Gross PPE

Veracyte (FRA:12V) Other Gross PPE : €88.4 Mil (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Veracyte Other Gross PPE?

Veracyte's Other Gross PPE for the quarter that ended in Dec. 2024 was €88.4 Mil.

Veracyte's quarterly Other Gross PPE declined from Jun. 2024 (€37.5 Mil) to Sep. 2024 (€34.4 Mil) but then increased from Sep. 2024 (€34.4 Mil) to Dec. 2024 (€88.4 Mil).

Veracyte's annual Other Gross PPE increased from Dec. 2022 (€41.6 Mil) to Dec. 2023 (€43.5 Mil) and increased from Dec. 2023 (€43.5 Mil) to Dec. 2024 (€88.4 Mil).


Veracyte Other Gross PPE Historical Data

The historical data trend for Veracyte's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veracyte Other Gross PPE Chart

Veracyte Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.84 37.33 41.59 43.47 88.38

Veracyte Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.47 30.11 37.54 34.44 88.38

Veracyte Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Veracyte Business Description

Traded in Other Exchanges
Address
6000 Shoreline Court, Suite 300, South San Francisco, CA, USA, 94080
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

Veracyte Headlines

No Headlines